stemedica.comBioTechFounded: 2005Funding to Date: $82.12MM
Stemedica Cell Technologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions.
For more details on financing and valuation for Stemedica, register or login.
Already registered? Click here to log in
To read this article and more news on Stemedica, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.